Congestive heart failure: The case for decreased variability as a unifying theme

Journal of Clinical and Basic Cardiology

Volumn 3, Issue 2, 2000, Pages 111-113

  Peters, Robert M ^a,b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Congestive heart failure; Variability

Indexed keywords

ADAPTATION; CARDIOVASCULAR FUNCTION; CONCEPT FORMATION; CONGESTIVE HEART FAILURE; EXERCISE; HEART OUTPUT; HEART RATE VARIABILITY; HEMODYNAMIC MONITORING; HUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0033802058     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Spectral analysis of R-R variability to evaluate autonomic physiology and pharmacology and to predict cardiovascular outcomes
2. Heart rate variability. Standards of measurements, physiological interpretation, and clinical use
3. Cardiac interbeat interval dynamics from childhood to senescence, comparison of conventional and new measures based on fractals and chaos theory
4. Vasodilators
5. Pathophysiology of heart failure
6. Clinical applicability of echocardiographically detected regional wall-motion abnormalities provoked by upright treadmill exercise
7. Abnormalities in cardiac relaxation and other forms of diastolic dysfunction
8. Pathophysiology of the heart failure clinical syndrome
9. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure
10. Sympathetic activation in heart failure and its treatment with β-blockade
11. The sympathetic nervous system in congestive heart failure
12. Adverse consequences of high sympathetic nervous activity in the failing human heart
13. Defective cardiac parasympathetic control in patients with heart disease
14. Nonadrenergic hormonal alterations in congestive heart failure
15. Relation of reninangiotensin-aldosterone system to clinical state in congestive heart failure
16. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD)
17. Arginine vasopressin and the renal response to water loading in congestive heart failure
18. Atrial natruiretic factor in normal subjects and heart failure patients: Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion
19. Pathophysiology of the heart failure clinical syndrome
20. Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials
21. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
22. Hormones and hemodynamics in heart failure
23. Prostaglandins in heart failure: Relation to activation of the renin-angiotensin system and hyponatremia
24. Pathophysiology of heart failure clinical syndrome
25. Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure
26. Regional blood flow in congestive heart failure. Concept of compensatory mechanisms with short and long term constants
27. Pathophysiology of heart failure
28. Pathophysiology of the heart failure syndrome
29. Regional blood flow response in patients with congestive heart failure
30. The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure
31. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy
32. Clinical, hemodynamic, and sympathetic neural correlates of heart rate variability in congestive heart failure
33. Decreased spontaneous heart rate variability in congestive heart failure
34. Pathophysiology of heart failure
35. Correlates and prognostic implication of exercise capacity in chronic heart failure
36. Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance
37. Clinical aspects of heart failure
38. Effect of captopril on cardiac parasympathetic activity in chronic cardiac failure secondary to coronary artery disease